Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects
NCT01913002
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LX4211 800 mg
DRUG:
LX4211 2000 mg
DRUG:
moxifloxacin 400 mg
DRUG:
LX4211 Placebo
Sponsor
Lexicon Pharmaceuticals